13 Best Diversified Dividend Stocks to Buy Right Now

10. Colgate-Palmolive Company (NYSE:CL)

Number of Hedge Fund Holders: 62

On March 30, Deutsche Bank upgraded Colgate-Palmolive Company (NYSE:CL) to Buy from Hold. It raised its price target to $98 from $90. The firm said the recent selloff has created a buying opportunity. The analyst described Colgate as having a “quality and durable” core franchise that is “making the right long-term investments.” The firm also said the company has the “flexibility to weather current volatility,” according to the research note.

On March 12, the Board of Directors of Colgate-Palmolive announced an increase in its quarterly common stock cash dividend to $0.53 per share, up from $0.52. The increase will take effect in the second quarter of 2026. On an annualized basis, the new rate stands at $2.12 per share, compared to $2.08 previously. The company has paid uninterrupted dividends on its common stock since 1895.

Separately, the company announced that Christopher Boerner, Ph.D., Board Chair and Chief Executive Officer of Bristol-Myers Squibb Company, has been elected to Colgate-Palmolive’s Board of Directors, effective March 15, 2026.

Colgate-Palmolive Company (NYSE:CL) is a growth-focused business centered on Oral Care, Personal Care, Home Care, and Pet Nutrition. It sells products under a range of brands. Its Oral, Personal, and Home Care segment is managed across five geographic regions: North America, Latin America, Europe, Asia Pacific, and Africa/Eurasia. These segments serve a mix of traditional and e-commerce retailers, wholesalers, distributors, dentists, and skin health professionals.